ReviewCureus2025
A Systematic Review of Cardiovascular Health Screening in Michigan: Are We Doing Enough?
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Rapid community "Healthy Heart" screening to identify people at high risk of cardiovascular events.PloS one · 2026Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease (CVD) remains the leading cause of death in the United States, with persistent disparities in access to preventive screening. This systematic review investigates how racial, geographic, and socioeconomic factors influence cardiovascular screening rates across Michigan, focusing on blood pressure and cholesterol screening across various groups. A systematic search of PubMed, Embase, Scopus, Web of Science, and Google Scholar was conducted for studies published through October 2025. Eligible studies reported Michigan-specific data on preventive cardiovascular screening, operationally defined as blood pressure measurement, and/or lipid testing in adults. Twelve studies met the inclusion criteria, and methodological quality was assessed using study-design-appropriate appraisal tools, including the NIH quality assessment instrument. Across studies, Black, rural, uninsured, and low-income populations consistently demonstrated lower screening rates compared with White, urban, and insured groups. Reported disparities in screening ranged from approximately 5%-15% points across racial and socioeconomic strata, depending on population and data source. Policy and community-based interventions, including Medicaid expansion and mobile screening initiatives, were associated with modest increases in screening, although effects were variable and not uniformly sustained. Overall, preventive cardiovascular screening in Michigan remains unevenly distributed, highlighting persistent equity gaps and the need for more consistent, statewide screening strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.